A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients

[1]  H. Nawa,et al.  Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients , 2002, Psychiatry Research.

[2]  H. Möller,et al.  Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. , 2002, The American journal of psychiatry.

[3]  A. Kakita,et al.  A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients , 2001, Neuroscience Letters.

[4]  A. Young,et al.  Raised levels of plasma interleukin‐1β in major and postviral depression , 2001, Acta psychiatrica Scandinavica.

[5]  H Nawa,et al.  Cytokine and growth factor involvement in schizophrenia—support for the developmental model , 2000, Molecular Psychiatry.

[6]  M. Lynch,et al.  The Inhibitory Effect of Interleukin-1β on Long-Term Potentiation Is Coupled with Increased Activity of Stress-Activated Protein Kinases , 2000, The Journal of Neuroscience.

[7]  K Maeda,et al.  Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients , 2000, Molecular Psychiatry.

[8]  E. Bosmans,et al.  Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist , 2000, Schizophrenia Research.

[9]  L. Garey,et al.  Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics , 2000, Journal of neuropathology and experimental neurology.

[10]  Dirk E. Smith,et al.  Four New Members Expand the Interleukin-1 Superfamily* , 2000, The Journal of Biological Chemistry.

[11]  J. Licinio,et al.  Cytokines in affective disorders and schizophrenia: new clinical and genetic findings , 1999, Molecular Psychiatry.

[12]  K. Akiyama.  Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration , 1999, Schizophrenia Research.

[13]  M. Hurme,et al.  Polymorphisms of the interleukin-1 gene complex in schizophrenia , 1999, Molecular Psychiatry.

[14]  H. Anisman,et al.  Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features , 1999, Molecular Psychiatry.

[15]  Masatoshi Suzuki,et al.  Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.

[16]  C. Plata-salamán,et al.  Interleukin-1β System (Ligand, Receptor Type I, Receptor Accessory Protein and Receptor Antagonist), TNF-α, TGF-β1 and Neuropeptide Y mRNAs in Specific Brain Regions During Bacterial LPS-Induced Anorexia , 1998, Brain Research Bulletin.

[17]  M. Ackenheil,et al.  Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[18]  M. Satoh,et al.  β2-Adrenoceptors on the glial cells mediate the induction of interleukin-1β mRNA in the rat brain , 1997 .

[19]  S. Kanba,et al.  Immobilization Stress Increases mRNA Levels of Interleukin-1 Receptor Antagonist in Various Rat Brain Regions , 1997, Cellular and Molecular Neurobiology.

[20]  S. Kanba,et al.  Induction of interleukin-1β and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain , 1996, Neuroscience Letters.

[21]  H. Meltzer,et al.  Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs , 1996, Schizophrenia Research.

[22]  R. Wyatt,et al.  Serum cytokine concentrations in patients with schizophrenia , 1996, Schizophrenia Research.

[23]  A. Dunn,et al.  Cytokine effects on CNS biogenic amines. , 1995, Neuroimmunomodulation.

[24]  P. Sawchenko,et al.  Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.

[25]  S. Kanba,et al.  Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  M. Satoh,et al.  Localization of type I interleukin-1 receptor mRNA in the rat brain. , 1994, Brain research. Molecular brain research.

[27]  R. Rimón,et al.  Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disorders , 1994, Schizophrenia Research.

[28]  M. Wong,et al.  Localization of interleukin 1 type I receptor mRNA in rat brain. , 1994 .

[29]  G. Hemmings,et al.  Changes of Plasma Concentrations of Interleukin-1α and Interleukin-6 with Neuroleptic Treatment for Schizophrenia , 1994, British Journal of Psychiatry.

[30]  J. Krystal,et al.  Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. , 1993, The American journal of psychiatry.

[31]  S. Kanba,et al.  Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  E. O'callaghan,et al.  Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. , 1992 .

[33]  M. Satoh,et al.  Induction of Interleukin‐1β mRNA in Rat Brain After Transient Forebrain Ischemia , 1992 .

[34]  R. Murray,et al.  Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic , 1991, The Lancet.

[35]  I. Bitter,et al.  The concept of the neuroleptic threshold: an update. , 1991, Journal of clinical psychopharmacology.

[36]  R. Chizzonite,et al.  Purification of homogeneity and amino acid sequence analysis of a receptor protein for interleukin 1. , 1989, Archives of biochemistry and biophysics.

[37]  R. Sapolsky,et al.  Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. , 1987, Science.

[38]  H. Besedovsky,et al.  Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. , 1987, Science.

[39]  R. Ganguli,et al.  Clinical and Laboratory Evidence of Autoimmunity in Acute Schizophrenia , 1987, Annals of the New York Academy of Sciences.

[40]  A. Darvasi,et al.  Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder , 2002, Molecular Psychiatry.

[41]  A. Kakita,et al.  Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients , 2002, Molecular Psychiatry.